Literature DB >> 33716655

Novel Neuroimaging Biomarker for Sleep Quality in Insomnia Disorder: A Hypothalamus Resting State Study.

Shuang Ding1, Lijuan Gao1, Hanjiaerbieke Kukun1, Kai Ai2, Wei Zhao1, Chao Xie3, Yunling Wang1.   

Abstract

Despite striking progress in the understanding of the neurobiology of insomnia disorder (ID), about 40% of ID patients do not reach sustained remission with the primary treatments. It is necessary to reveal novel neuroimaging biomarkers for sleep quality in ID. The hypothalamus has a central role in sleep-wake regulation by communicating with different brain regions. However, the functional implications of hypothalamus circuitry with other brain areas remains largely unknown in ID. It may be speculated that dysfunctional circuitry in the hypothalamus is involved in the pathogenesis of ID. Thus, we investigated the different network organizations of the bilateral hypothalamus during the resting-state between 26 ID patients and 28 healthy controls (HC). Correlation analysis has been carried out to link the neuroimaging findings and Pittsburgh sleep quality index (PSQI) scores. Group comparisons reveal that the resting-state functional connectivity (RSFC) between the left hypothalamic region and a few other brain regions, including the medial prefrontal cortex (mPFC) and pallidum, are significantly higher in ID compared with HC. The right inferior temporal cortex showed reduced RSFC with the left hypothalamus. No significantly different RSFC between ID and HC was detected for the right hypothalamus. Positive correlations with PSQI scores were observed for RSFC strength between the left hypothalamus and bilateral mPFC (left: r = 0.2985, p = 0.0393; right: r = 0.3723, p = 0.0056). Similarly, the RSFC strength between the right hypothalamus and bilateral mPFC (left: r = 0.3980, p = 0.0029; right: r = 0.2972, p = 0.0291) also showed significant positive correlations with PSQI scores. In conclusion, we reveal a novel neuroimaging biomarker for sleep quality, i.e., the RSFC strength of the hypothalamus-mPFC pathway. Consistent with the hyperarousal model of ID, our results shed new insights into the implications of the hyper-connection within hypothalamus circuits in the pathology of the ID.
Copyright © 2021 Ding, Gao, Kukun, Ai, Zhao, Xie and Wang.

Entities:  

Keywords:  hypothalamus; insomnia disorder; medial prefrontal cortex; pittsburgh sleep quality index; resting state functional connectivity

Year:  2021        PMID: 33716655      PMCID: PMC7953135          DOI: 10.3389/fnins.2021.634984

Source DB:  PubMed          Journal:  Front Neurosci        ISSN: 1662-453X            Impact factor:   4.677


  38 in total

Review 1.  The sleep switch: hypothalamic control of sleep and wakefulness.

Authors:  C B Saper; T C Chou; T E Scammell
Journal:  Trends Neurosci       Date:  2001-12       Impact factor: 13.837

Review 2.  Insomnia: pathophysiology and implications for treatment.

Authors:  Thomas Roth; Timothy Roehrs; Ron Pies
Journal:  Sleep Med Rev       Date:  2006-12-18       Impact factor: 11.609

3.  An anatomic basis for the communication of hypothalamic, cortical and mesolimbic circuitry in the regulation of energy balance.

Authors:  J Kampe; M H Tschöp; J H Hollis; Brian J Oldfield
Journal:  Eur J Neurosci       Date:  2009-07-15       Impact factor: 3.386

Review 4.  Neuroimaging findings in primary insomnia.

Authors:  J N O'Byrne; M Berman Rosa; J-P Gouin; T T Dang-Vu
Journal:  Pathol Biol (Paris)       Date:  2014-08-14

5.  Regional homogeneity changes in patients with primary insomnia.

Authors:  Tianyue Wang; Shumei Li; Guihua Jiang; Chulan Lin; Meng Li; Xiaofen Ma; Wenfeng Zhan; Jin Fang; Liming Li; Cheng Li; Junzhang Tian
Journal:  Eur Radiol       Date:  2015-09-08       Impact factor: 5.315

Review 6.  Hypothalamic regulation of the sleep/wake cycle.

Authors:  Daisuke Ono; Akihiro Yamanaka
Journal:  Neurosci Res       Date:  2017-05-17       Impact factor: 3.304

7.  Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial.

Authors:  Charles M Morin; Annie Vallières; Bernard Guay; Hans Ivers; Josée Savard; Chantal Mérette; Célyne Bastien; Lucie Baillargeon
Journal:  JAMA       Date:  2009-05-20       Impact factor: 56.272

Review 8.  Primary insomnia: a risk factor to develop depression?

Authors:  Dieter Riemann; Ulrich Voderholzer
Journal:  J Affect Disord       Date:  2003-09       Impact factor: 4.839

9.  Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease.

Authors:  Gennaro Pagano; Sophie Molloy; Peter G Bain; Eugenii A Rabiner; K Ray Chaudhuri; David J Brooks; Nicola Pavese
Journal:  Neurology       Date:  2016-11-02       Impact factor: 9.910

10.  Alterations in hypothalamus-pituitary-adrenal/thyroid axes and gonadotropin-releasing hormone in the patients with primary insomnia: a clinical research.

Authors:  Lan Xia; Gui-Hai Chen; Zhi-Hua Li; Song Jiang; Jianhua Shen
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.